A new technique for in vivo imaging of specific GLP-1 binding sites: First results in small rodents

Regulatory Peptides

Volumn 137, Issue 3, 2006, Pages 162-167

  Gotthardt, Martin ^a   Lalyko, Georg ^b   van Eerd Vismale, Julliëtte ^a   Keil, Boris ^b   Schurrat, Tino ^b   Hower, Michael ^b   Laverman, Peter ^a   Behr, Thomas M ^b   Boerman, Otto C ^a   Göke, Burkhard ^c   Béhé, Martin ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Exendin 4; GLP 1; Magnetic resonance imaging; Receptor imaging; Single photon emission computed tomography; Small animal imaging

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INDIUM 111; PENTETATE INDIUM; PENTETIC ACID DERIVATIVE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; HYPOPHYSIS; IN VIVO STUDY; LUNG; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PRIORITY JOURNAL; RADIOCHEMISTRY; RAT; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH;

ANIMALS; BINDING SITES; GLUCAGON-LIKE PEPTIDE 1; IMAGE PROCESSING, COMPUTER-ASSISTED; INDIUM RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; PENTETIC ACID; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENOMS;

ANIMALIA; RODENTIA;

EID: 33751515577     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.07.005     Document Type: Article

References (35)

1. Meier J.J., and Nauck M.A. Glucagon-like peptide 1 (GLP-1) in biology and pathology. Diabetes Metab Res Rev 21 (2005) 91-117
2. Lankat-Buttgereit B., Göke R., Stöckmann F., Jiang J., Fehmann H.C., and Göke B. Detection of the human GLP-1(7-36) amide receptor on insulinoma-derived cell membranes. Digestion 55 1 (1994) 29-33
3. Horowitz M., O ́Donovan D., Jones K.L., Fienle C., Rayner C.K., and Samsom M. Gastric emptying in diabetes: clinical significance and treatment. Diabetic Med 19 (2002) 177-194
4. Nielsen L.L., Young A.A., and Parks D.G. Pharmacology of Exenatide (synthetic exendin-1): a potential therapeutic for improved glycemic control for diabetes type 2. Reg Peptides 117 (2004) 77-88
5. Turton M.D., O ́Shea D., Gunn I., Beak S.A., and Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 (1996) 69-72
6. Schick R.R., Zimmermann J.P., vorm Walde T., and Schusdziarra V. Peptides that regulate food intake: glucagon-like peptide-1 (7-36) amide at lateral and medial hypothalamic sites to suppress feeding in rats. Am J Physio 284 (2003) R1427-R1435
7. Reubi J.C. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J Nucl Med 36 (1995) 1825-1835
8. Meier J.J., Gallwitz B., Schmidt W.E., and Nauck M.A. Glucagon-like peptide 1 (GLP-1) as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 440 (2002) 269-279
9. Ørskov C., Poulsen S.S., Møller M., and Holst J.J. Glucagon-like peptide 1 receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide 1. Diabetes 45 (1996) 832-835
10. Kastin A.J., Akerstrom V., and Pan W. Interactions of glucagons-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci 18 (2002) 7-14
11. Schmidtler J., Dehne K., Allescher H.D., Schusdziarra V., Classen M., Holst J.J., et al. Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding. Am J Physiol 267 (1994) G423-G432
12. Lankat-Buttgereit B., Göke R., Fehmann H.C., Richter G., and Göke B. Molecular cloning of cDNA encoding for the GLP-1 receptor expressed in rat lung. Exp Clin Endocrinol 102 (1994) 341-347
13. Richter G., Göke R., Göke B., and Arnold R. Characterization of receptors for GLP-1(7-36) amide on rat lung membranes. FEBS Lett 267 (1990) 78-80
14. Bullock B.P., Heller R.S., and Habener J.F. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137 (1996) 2968-2978
15. Thorens B. Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon-like peptide-1. Proc Natl Acad Sci U S A 89 (1992) 8641-8645
16. Ørskov C., and Poulsen S.S. Autoradiography of rat tissues with GLP-1. Diabetes 40 (1991) 1992-1996
17. Valverde I., Mérida E., Delgado E., Trapote M.A., and Villanueva-Peñacarrillo M.L. Presence and characterization of glucagon-like peptide-1 (7-36) amidereceptors in solubilized membranes of rat adipose tissue. Endocrinology 132 (1993) 75-79
18. Sandhu H., Wiesenthal S.R., MacDonald P.E., McCall R.H., Tchipashvili V., Rashid S., et al. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes 48 (1999) 1045-1053
19. 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera. Nucl Med Biol 26 (1999) 413-420
20. Goke R., Larsen P.J., Mikkelsen J.D., and Sheikh S.P. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7 (1995) 2294-2300
21. Singh G., Eng J., and Raufman J.P. Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig. Regul Pept 53 (1994) 47-59
22. Gotthardt M., Boerman O.C., Behr T.M., Béhé M.P., and van Oyen W.J.G. Peptide-based radiopharmaceuticals: development, clinical application, and future perspectives. Curr Pharm Des 10 (2004) 2951-2963
23. Gotthardt M., Fischer M., Holz J.B., Jungclas H., Fritsch H.W., Béhé M., et al. Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: first experimental results. Eur J Nucl Med Mol Imaging 29 (2002) 597-606
24. Reubi J.C., and Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor imaging. Eur J Nucl Med Mol Imaging 30 (2003) 781-793
25. Eng J., Kleinman W.A., Singh L., Singh G., and Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267 (1992) 7402-7405
26. Edwards C.M., Stanley S.A., Davis R., Brynes A.E., Frost G.S., Seal L.J., et al. Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab 281 (2001) E155-E161
27. 111In-labeled GLP-1 analog for the scintigraphic diagnosis of neuroendocrine tumors. J Nucl Med 46 2 (2005) 91 pp.
28. Behr T.M., Gotthardt M., Becker W., and Béhé M. Radioiodination of monoclonal antibodies, proteins, and peptides for diagnosis and therapy: a review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Göttingen/Marburg experience. Nuklearmedizin 41 (2002) 71-79
29. Béhé M., Becker W., Gotthardt M., Angerstein C., and Behr T.M. Improved kinetic stability of DTPA-d-Glu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives. Eur J Nucl Med Mol Imaging 30 (2003) 1140-1146
30. Schramm N.U., Ebel G., Engeland U., Schurrat T., Behe M., and Behr T.M. High-resolution SPECT using multi-pinhole collimation. IEEE Trans Nucl Sci 50 (2002) 315-320
31. Schepp W., Schmidtler J., Riedel T., Dehne K., Schusdziarra V., Holst J.J., et al. Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2. Eur J Pharmacol 269 (1994) 183-191
32. De Jong M., Barone R., Krenning E., Bernard B., Melis M., Visser T., et al. Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide. J Nucl Med 46 (2005) 1696-1700
33. Melis M., Krenning E.P., Bernard B.F., Barone R., Viser T.J., and de Jong M. Localization and mechanism of renal retention of radiolabeled somatostatin analogues. Eur J Nucl Med Mol Imaging 32 (2005) 1136-1143
34. Bock T., Svenstrup K., Pakkenberg B., and Buschard K. Unbiased estimation of total beta-cell number and mean beta-cell volume in rodent pancreas. APMIS 107 (1999) 791-799
35. Wild D., Béhé M., Wicki A., Christofori G., Waser B., Gotthardt M., et al. Preclinical evaluation of an In-111 labeled Exendin-4 derivative, a very promising ligand for glucagons-like peptide-1 (GLP-1) receptor targeting. Mol Imaging 4 3 (2005) 328